Answers are grounded in this paper and cite their sources.
Observational analysis reveals increased reactive gliosis in mouse models lacking BIS, suggesting critical roles in CNS recovery.
BIS (Bcl-2-interacting cell death suppressor, or BAG-3), is a multifunctional co-chaperone that maintains protein quality control via autophagy and proteostasis. Following the central nervous system (CNS) injury, BIS expression is markedly upregulated in reactive astrocytes, suggesting a regulatory role of reactive astrogliosis. To investigate this, we generated astrocyte-specific BIS knockout (BIS-aKO) mice for the first time. While BIS-aKO mice exhibited normal growth and survival, the injury-induced upregulation of BIS expression was abolished in reactive astrocytes following excitotoxic injury. Using a photothrombotic stroke model, we found that astrocytic BIS deficiency resulted in significantly increased GFAP expression in scar-forming astrocytes at the infarct border and altered morphology in the peri-infarct region. Furthermore, we observed increased infiltration of amoeboid Iba1-positive cells in the astroglial scar, indicating enhanced neuroinflammation. Correlative light-and electron-microscopy following both stroke and stab wound injury revealed BIS-aKO astrocytes exhibited a greater density of intermediate filament filling in their soma and processes, along with relatively fewer cytoplasmic organelles, such as mitochondria. Collectively, these findings highlight a previously unrecognized role of BIS in modulating reactive gliosis during brain injury and our model provides a valuable tool for investigating the astrocyte-specific functions of BIS in CNS pathophysiology.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: